These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33455917)

  • 1. Cyclosporine: hope for severe COVID-19?
    Pathania YS
    BMJ Support Palliat Care; 2021 Jan; ():. PubMed ID: 33455917
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine and COVID-19: Risk or favorable?
    Poulsen NN; von Brunn A; Hornum M; Blomberg Jensen M
    Am J Transplant; 2020 Nov; 20(11):2975-2982. PubMed ID: 32777170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential Use of Cyclosporine Ultrafine Solution Pressurised Metered- Dose Inhaler in the Treatment of COVID-19 Patients.
    Ehtezazi T
    Recent Adv Drug Deliv Formul; 2022; 16(1):3-15. PubMed ID: 34809553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pure red cell aplasia accompanied by COVID-19 successfully treated using cyclosporine.
    Yamazaki S; Naito E; Sekiya R; Yogi S; Komiyama K; Miyakawa Y; Nagata M
    J Infect Chemother; 2022 Feb; 28(2):304-307. PubMed ID: 34772624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease: A pilot study.
    Gálvez-Romero JL; Palmeros-Rojas O; Real-Ramírez FA; Sánchez-Romero S; Tome-Maxil R; Ramírez-Sandoval MP; Olivos-Rodríguez R; Flores-Encarnación SE; Cabrera-Estrada AA; Ávila-Morales J; Cortés-Sánchez V; Sarmiento-Padilla G; Tezmol-Ramírez SE; Aparicio-Hernández D; Urbina-Sánchez MI; Gómez-Pluma MÁ; Cisneros-Méndez S; Rodríguez-Rivas DI; Reyes-Inurrigarro S; Cortés-Díaz G; Cruz-Delgado C; Navarro-González J; Deveaux-Homs J; Pedraza-Sánchez S
    J Intern Med; 2021 Jun; 289(6):906-920. PubMed ID: 33274479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine as a preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.
    Kemmner S; Guba MO; Schönermarck U; Stangl M; Fischereder M
    Kidney Int; 2020 Aug; 98(2):507-508. PubMed ID: 32505466
    [No Abstract]   [Full Text] [Related]  

  • 8. Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2?
    Rodriguez-Cubillo B; de la Higuera MAM; Lucena R; Franci EV; Hurtado M; Romero NC; Moreno AR; Valencia D; Velo M; Fornie IS; Sanchez-Fructuoso AI
    Am J Transplant; 2020 Nov; 20(11):3173-3181. PubMed ID: 32529737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19.
    Liu C; von Brunn A; Zhu D
    Med Drug Discov; 2020 Sep; 7():100056. PubMed ID: 32835213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?
    Cour M; Ovize M; Argaud L
    Crit Care; 2020 Jun; 24(1):276. PubMed ID: 32487139
    [No Abstract]   [Full Text] [Related]  

  • 11. Hope Levels and Resilience in Patients with Severe Novel Coronavirus Pneumonia: The Current Situation and a Correlation Analysis.
    Zhong GQ; Lin BH; Xiao CX
    Int J Gen Med; 2021; 14():1959-1965. PubMed ID: 34040427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Pandemic: Time to Revive the Cyclophilin Inhibitor Alisporivir.
    Pawlotsky JM
    Clin Infect Dis; 2020 Nov; 71(16):2191-2194. PubMed ID: 32409832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A COVID-19 Risk Reduction Strategy for the Treatment of Acute Vogt-Koyanagi-Harada Disease Utilizing the Antiviral Potential of Cyclosporine.
    Nakayama M; Okada AA; Hayashi I; Ando Y; Watanabe T; Keino H
    Ocul Immunol Inflamm; 2023 Feb; 31(2):462-467. PubMed ID: 35167414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2.
    Guareschi F; Del Favero E; Ricci C; Cantù L; Brandolini M; Sambri V; Nicoli S; Pescina S; D'Angelo D; Rossi I; Buttini F; Bettini R; Sonvico F
    Eur J Pharm Sci; 2024 Feb; 193():106673. PubMed ID: 38103657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hope over fear: The interplay between threat information and hope appeal corrections in debunking early COVID-19 misinformation.
    Tao R; Li J; Shen L; Yang S
    Soc Sci Med; 2023 Sep; 333():116132. PubMed ID: 37556993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease.
    Loftus CG; Egan LJ; Sandborn WJ
    Gastroenterol Clin North Am; 2004 Jun; 33(2):141-69, vii. PubMed ID: 15177532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical ophthalmic cyclosporine: pharmacology and clinical uses.
    Donnenfeld E; Pflugfelder SC
    Surv Ophthalmol; 2009; 54(3):321-38. PubMed ID: 19422961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile.
    Takeda A; Horike K; Onoda H; Ohtsuka Y; Yoshida A; Uchida K; Morozumi K
    Nephrology (Carlton); 2007 Apr; 12(2):197-204. PubMed ID: 17371346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin for treatment of refractory multisystemic inflammatory syndrome in a child.
    Gámez-González LB; Hamada H; Yamazaki-Nakashimada MA
    Cardiol Young; 2023 May; 33(5):800-802. PubMed ID: 36052505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of mechanisms of Shenhuang Granule in treating severe COVID-19 based on network pharmacology and molecular docking.
    Xu XR; Zhang W; Wu XX; Yang HQ; Sun YT; Pu YT; Wang B; Peng W; Sun LH; Guo Q; Zhou S; Fang BJ
    J Integr Med; 2022 Nov; 20(6):561-574. PubMed ID: 35934629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.